Teicoplanin for treating MRSA pneumoniaBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g2317 (Published 25 March 2014) Cite this as: BMJ 2014;348:g2317
- J Mukhopadhyay, respiratory physician1
- 1South Warwick Hospitals NHS Trust, Warwick CV 34 5BW, UK
Muscedere concludes that vancomycin is non-inferior to linezolid in the treatment of meticillin resistant Staphylococcus aureus (MRSA) pneumonia.1 This is interesting given the cost implications. However, one advantage of linezolid that needs to be factored into the cost calculations is that it can be given orally, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial